abstract |
The present invention relates to novel compounds that inhibit LRRK2 kinase activity, their preparation methods, compositions containing them, and their use in the treatment or prevention of diseases related to or characterized by LRRK2 kinase activity, such as Parkinson ’s Alzheimer's disease and amyotrophic lateral sclerosis (ALS). |